A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription by Musahl, A. et al.
ORIGINAL ARTICLE
A long non-coding RNA links calreticulin-mediated
immunogenic cell removal to RB1 transcription
A-S Musahl1, X Huang2,3,4, S Rusakiewicz5,6, E Ntini1, A Marsico7,8,9, G Kroemer2,3,4,10,11, O Kepp2,3,4 and UA Ørom1
A subset of promoters bidirectionally expresses long non-coding RNAs (ncRNAs) of unknown function and protein-coding genes
(PCGs) in parallel. Here, we deﬁne a set of 1107 highly conserved human bidirectional promoters that mediate the linked expression
of long ncRNAs and PCGs. Depletion of the long ncRNA expressed from the RB1 promoter, ncRNA-RB1, reveals regulatory effects
different from the RB1-controlled transcriptional program. ncRNA-RB1 positively regulates the expression of calreticulin (CALR) that
in response to certain therapeutic interventions can translocate from the endoplasmic reticulum to the cell surface, hence
activating anticancer immune responses. Knockdown of ncRNA-RB1 in tumor cells reduced expression of CALR, impaired the
translocation of the protein to the cell surface upon treatment with anthracylines and consequently inhibited the cellular uptake by
macrophages. In conclusion, co-transcription of ncRNA-RB1 and RB1 provides a positive link between the expression of the two
tumor suppressors RB1 and the immune-relevant CALR protein. This regulatory interplay exempliﬁes disease-relevant co-regulation
of two distinct gene products, in which loss of expression of one oncosuppressor protein entails the abolition of additional tumor-
inhibitory mechanisms.
Oncogene advance online publication, 12 January 2015; doi:10.1038/onc.2014.424
INTRODUCTION
Several thousand long non-coding RNAs (ncRNAs), that is,
functional RNA transcripts not encoding proteins,1 are encoded
in the human genome.2,3 These transcripts generally display low
expression levels and high degrees of tissue speciﬁcity, suggesting
catalytic roles in the regulation of gene expression. Long ncRNAs
reportedly act on various levels of gene regulation mediating
either activation or repression of target genes while interacting
with a wide range of proteins.4–8 Initially, long ncRNAs have been
found to be involved in the recruitment of histone-modifying
complexes to chromatin, which has recently been expanded by
reports on the interaction of long ncRNAs with transcription
factors and their importance during the formation of co-activator
complexes.7–9
Research has mostly been focused on the functional character-
ization of long ncRNAs originating from genomic regions that do
not overlap with protein-coding genes (PCGs) and hence those
transcripts that are expressed from independent promoters.5,6,10,11
Although many genome-wide studies in a wide range of
organisms established that most PCG promoters are characterized
by divergent non-coding transcription, the functional role of those
promoter-associated long ncRNAs remains elusive.12–16 In many
cases, antisense transcripts upstream of promoters are unstable
and their emergence might be explained by aberrant transcription
initiation of RNA polymerase II due to the depletion of
nucleosomes on active promoters.14,17–20 In evolutionary terms,
divergent transcription initiation could fuel the emergence of new
functional genes, by exposing the transcribed DNA strand to
mutagenic alterations as has been reported for the acquisition of
splice sites.21
Several studies have addressed the regulation of bidirectional
transcription,13,16,18,19,22–27 with three of these shedding light on
the functionality of ncRNAs that are bidirectionally expressed from
human PCG promoters: Hung et al.28 investigated human cell
cycle-regulated genes and identiﬁed 58 functional long ncRNAs
that are co-expressed with PCGs from bidirectional promoters.
One of these transcripts, PANDA (P21 associated ncRNA DNA
damage activated), is induced by DNA damage at the CDKN1A
promoter and mediates regulation of pro-apoptotic genes.28 In
another study, human embryonic stem cells have been shown to
robustly express more than 2000 long ncRNAs bidirectionally from
within 2 kb of the transcription start sites (TSS) of PCGs.16
Transcriptional activation of speciﬁc PCGs via the induction of
cellular differentiation is coordinated with expression of paired
long ncRNAs, suggesting similar functional roles for bidirectionally
expressed genes.16 Furthermore, the long ncRNA Fendrr that
seems to be bidirectionally expressed from the Foxf1 promoter in
mouse and partly co-expressed with the Foxf1 transcript has been
shown to contribute to heart and body wall formation.29 The co-
expression of two genes from a bidirectional promoter suggests a
mutual regulation mediated by a shared upstream transcriptional
network, and implies that their functions might contribute to the
same cellular response independently.
Cancer cells expose proteins at their cell surface, which differ
from those of normal cells thereby serving as tumor antigens or
activating signals for immune cells.30,31 One of the recently
discovered ‘eat-me’ signals that are exposed on the cellular
1Noncoding RNA Research Group, Max Planck Institute for Molecular Genetics, Berlin, Germany; 2Team11, Equipe labellisée Ligue contre le Cancer, INSERM U1138, Cordeliers
Research Cancer, Paris, France; 3Université Paris Descartes, Sorbonne Paris Cité, Paris, France; 4Cell Biology and Metabolomics Platforms, Gustave Roussy Comprehensive Cancer
Center, Villejuif, France; 5Gustave Roussy, Villejuif, France; 6INSERM, U1015; CICBT507, Villejuif, France; 7Department of Computational Biology, Max Planck Institute for Molecular
Genetics, Berlin, Germany; 8RNA Bioinformatics group, Max Planck Institute for Molecular Genetics, Berlin, Germany; 9Free University of Berlin, Berlin, Germany; 10Université Pierre
et Marie Curie, Paris, France and 11Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Correspondence: Dr UA Orom, Otto Warburg Laboratories, Max
Planck Institute for Molecular Genetics, Ihnestrasse 63, Berlin 14195, Germany.
E-mail: Oerom@molgen.mpg.de
Received 22 August 2014; revised 7 October 2014; accepted 18 November 2014
Oncogene (2015), 1–9
© 2015 Macmillan Publishers Limited All rights reserved 0950-9232/15
www.nature.com/onc
surface during instances of immunogenic cell death (ICD) is
calreticulin (CALR). CALR is an endoplasmic reticulum sessile
chaperone that in response to certain chemotherapeutic agents
such as anthracyclines or oxaliplatin, translocates to the cellular
surface in a pre-apoptotic manner.32 Surface-exposed CALR then
serves as a de novo uptake signal to phagocytic cells of the
immune system. Thus, ICD can enable the eradication of
chemotherapy-resistant cancer cells.
In this study, we used the GENCODE V19 annotation of the
human genome to deﬁne a set of 1107 highly conserved
bidirectional promoters driving the expression of long ncRNAs
and PCGs. Most identiﬁed promoters are between 100 and 200 bp
in length, indicating their potential of bidirectional transcription
initiation, emphasizing the possibility of bidirectional expression
driven by the same set of transcription factors. For a subset of
these promoters we showed their potential to initiate bidirectional
transcription. Furthermore, we addressed the function of ncRNA-
RB1, a long ncRNA expressed from the RB1 promoter. Separate
depletion of ncRNA-RB1 and RB1 mRNA demonstrated that the
regulatory programs downstream of both genes contribute to
tumor suppressor activity.
RESULTS
To investigate the relationship between divergently encoded long
ncRNAs and PCGs in the human genome, we used the GENCODE
V19 annotation.3 We determined the distance between the TSSs of
each annotated long ncRNA and its closest PCG encoded on the
opposite DNA strand (Figures 1a and b).33 Within a region of 2 kb
around the TSSs of PCG promoters, a promoter size that has
previously been used to deﬁne PCG-associated long ncRNAs, we
found 3891 long ncRNA/PCG pairs.16 This set of long ncRNA/PCG
pairs exhibits a major enrichment of promoters between 100 and
200 bp in length separating the TSSs (Supplementary Figure 1),
which is in accordance with previous studies and supports the
idea that most long ncRNAs in our data set share a promoter with
their associated PCG rather than both genes being expressed from
distinct promoters.34
When ﬁltering for bidirectional promoters of up to 500 bp in
length, the set was narrowed down to nearly half (~45%) of the
initial PCG-associated long ncRNAs. After removing overlapping
genes, we recovered a ﬁnal set of 1107 bidirectional ncRNA/PCG
pairs (Figures 1a–c, Supplementary Table 1).
Several cancer-related proteins are expressed from bidirectional
ncRNA/PCG promoters, for example, the tumor suppressor
retinoblastoma 1 (RB1),35 Nuclear factor NF-kappa-B p100
subunit,36 glycogen synthase kinase-3 beta37 and Phosphatidyli-
nositol 4,5-bisphosphate 3-kinase38 (Supplementary Table 2).
Consistently, previous analyses of bidirectional PCG/PCG pairs
have shown that DNA-repair genes and genes implicated in
somatic cancer are frequently expressed from bidirectional
promoters, suggesting that such co-regulation is functionally
important.34,39
Analysis of conservation of the candidate bidirectional ncRNA/
PCG promoters showed signiﬁcantly higher conservation rates of
bidirectional ncRNA/PCG promoters as compared with the
average PCG promoter (P= 6.5 × 10− 5; Figure 1d), implying an
evolutionary conservation of the genomic head-to-head arrange-
ment of the 1107 candidate ncRNA/PCG pairs. This supports the
notion that co-regulation of both paired genes is physiologically
relevant.
To determine the potential of deﬁned promoters to initiate
bidirectional transcription, we tested four candidates (driving the
expression of CCNG1, FKTN, MAGOH and RB1 genes) in a reporter
assay. For the reporter assay the promoters were inserted into a
vector containing ﬁreﬂy and Renilla reniformis luciferase genes in a
head-to-head orientation to simultaneously measure the expres-
sion of both reporter genes (Figure 2a). For all candidates,
orientation of the promoter was directed so that ﬁreﬂy luciferase
activity represents the promoter strength in the PCG direction and
Renilla reniformis luciferase activity represents the promoter
strength relevant to the long ncRNA expression. All tested
promoters mediated high ﬁreﬂy luciferase activity, indicating their
potential to initiate transcription of paired ncRNAs and PCGs
(Figure 2b). Importantly, the four candidate bidirectional promo-
ters more efﬁciently expressed Renilla reniformis luciferase than do
two control promoters that appear predominantly unidirectional
(GAPDH and TK; Figure 2b). To determine the signiﬁcance of this
observation, we calculated the ratio between ﬁreﬂy and Renilla
reniformis luciferase activities for all tested promoters. A value
close to 1 implied a high bidirectional potential of a promoter,
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Figure 1. Transcription of long ncRNAs and PCGs from bidirectional promoters. (a) Criteria for promoters and long ncRNAs to deﬁne 1107
candidate bidirectional promoters of long ncRNA/PCG pairs in the human genome. (b) Schematic of genomic arrangement of deﬁned long
ncRNA/PCG pairs (orange and blue, respectively), which are listed in Supplementary Table 1. (c) Density plot showing the distribution of
distances between TSSs of divergently encoded long ncRNA/PCG pairs (1 kb window), for those long ncRNAs not overlapping a PCG
throughout their genomic region. (d) Density plot showing the distribution of conservation scores for promoters of bidirectional ncRNA/PCG
pairs, PCG, long ncRNAs and random regions. Bidirectional ncRNA/PCG promoters exhibit signiﬁcantly higher conservation rates than the
average PCG promoters (P= 6.5 × 10− 5).
A ncRNA regulating CALR
A-S Musahl et al
2
Oncogene (2015), 1 – 9 © 2015 Macmillan Publishers Limited
low values (CCNG1= 0.30, FKTN= 0.22, MAGOH=0.38, RB1= 0.43,
GAPDH=0.01 and TK = 0.07). Importantly, the values for candidate
bidirectional promoters were signiﬁcantly higher than for control
promoters (P⩽ 0.001).
Next, we determined relative transcript levels of three ncRNA/
PCG pairs across nine cell lines using quantitative reverse
transcriptase (qRT)–PCR. For the CCNG1, PRKCQ and RB1
promoters, both transcripts were detectable in each of the cell
lines examined. Expression levels for ncRNAs and respective
mRNAs differed in several orders of magnitude and showed
various degrees of correlation, as determined by calculating
Pearson correlation coefﬁcients (RCCNG1 = 0.86, RPRKCQ = 0.88,
RRB1 = 0.41 (Figures 2c–e). A high correlation between endo-
genous ncRNA and PCG expression was observed for the CCNG1
and PRKCQ promoters, whereas the correlation for RB1 was
less pronounced, potentially due to additional regulation of
transcription and transcript stability.
Among the candidate promoters, the one driving expression of
RB1 has been intensively studied. Within the RB1 promoter
sequence, binding sites of at least ﬁve transcription factors that
are responsible for regulated expression of the RB1 gene have
been identiﬁed: ATF,40 p53,41 E2F1,42 E4TF143 and Sp140
(Figure 3a). ATF, SP1 and E4TF1 are activators of the RB1
gene,40,44,45 and p53 and E2F1 (in complex with pRB1 itself) act as
repressors.41,46 The TSSs of RB1 and ncRNA-RB1 are separated by a
GC-rich 114-bp-long promoter region. As it is often observed in
metazoan GC-rich promoters, the ncRNA-RB1/RB1 promoter lacks
a TATA box,47 further supporting the bidirectional nature of the
region. Studies of the RB1 promoter have described that deletion
of a 17-bp region overlapping the binding sites of SP1, ATF and
E2F1 completely abrogates promoter activity in the RB1
direction.44 We observed that this deletion not only reduces the
promoter activity in the RB1 direction, but also decreased that in
the ncRNA-RB1 direction, when introduced into the bidirectional
luciferase vector (Figure 3b). We further showed the co-regulation
Bidirectional
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Figure 2. ncRNA/PCG expression from bidirectional promoters. (a) Schematic of the reporter vector to determine bidirectional promoter
activity. Promoters are inserted so that Fireﬂy luciferase activity represents the promoter strength in the PCG direction and Renilla luciferase
activity represents the promoter strength in the ncRNA direction. (b) Bidirectional promoter activities of CCNG1, FKTN, MAGOH and RB1
candidate bidirectional promoters and GAPDH and TK as control promoters are represented by the relative luciferase units for both Fireﬂy and
Renilla luciferases. Mean values± s.d. are shown, n⩾ 3 replicates. ***Po0.005. (c–e) Relative expression levels of paired transcripts. (c) CCNG1,
(d) PRKCQ and (e) RB1 promoters as determined by qRT–PCR. The y axis represents ncRNA expression level and the x-axis represents mRNA
expression level for nine cell lines (A549, HEK293, HeLa, HepG2, IMR90, K562, MCF7, Thp1 and U2OS). Expression values are presented relative
to the value of Actin as reference gene. Mean values± s.d. are shown, n⩾ 3 replicates.
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of transcription initiation by the RB1 promoter by introducing two
distinct retinoblastoma-associated mutations into the Luciferase
reporter, that are located within the ATF and SP1 transcription
factor-binding sites.40 Both point mutations dramatically reduced
the bidirectional RB1 promoter activity, potentially also contribut-
ing to ncRNA-RB1 expression in vivo (Figure 3b).
ncRNA-RB1 is encoded by a 7.1-kb region 114 bp upstream of
the RB1 gene. The transcript is annotated to consist of two
isoforms with a maximum size of 1.14 kb (Figure 3c). We
determined the subcellular distribution of ncRNA-RB1 transcript
levels by cellular fractionation of A549 cells followed by RNA
isolation and qRT–PCR. This shows a predominantly nuclear
localization of ncRNA-RB1 (Figure 3d).
To gain insight into the regulatory functions of ncRNA-RB1 and
to infer the involvement of this ncRNA within regulatory circuits of
RB1, we individually depleted both transcripts from A549 cells
using small interfering RNAs (siRNAs). Knockdown of both
transcripts was efﬁcient, yielding a 60–80 percent decrease of
transcript levels (Figures 4a and d). Furthermore, reduction in RB1
protein levels following knockdown of RB1 mRNA was conﬁrmed
by western blot analysis (Figure 4e). When depleting ncRNA-RB1
no effects on RB1 transcript or protein levels were observed
(Figures 4a, b and e). Likewise, depletion of RB1 mRNA did not
affect the expression of ncRNA-RB1 (Figures 4c and d) suggesting
that the two transcripts do not regulate each other but rather






















































































Figure 3. The ncRNA-RB1/RB1 promoter and genomic locus. (a) Schematic of the ncRNA-RB1 promoter. ncRNA-RB1 and RB1 TSSs are
separated by a 114-nucleotide promoter region that encodes the binding sites of ATF, E2F, p53 and SP1 transcription factors. Two
retinoblastoma-associated point mutations in the ATF (G→ T, red) and SP1 binding sites (G→A, red) are shown. (b) Bidirectional RB1 promoter
activities of the wild-type promoter (WT), the promoter with deleted SP1, ATF and E2F binding sites (ΔSP1, ΔATF and ΔE2F), the RB1 promoter
with mutated SP1-binding site (SP1 Mut) and the RB1 promoter with mutated ATF-binding site (ATF Mut) are represented by relative luciferase
units for both Fireﬂy and Renilla luciferases. The mean values± s.d. are shown, n⩾ 3 replicates. **Po0.01, ***Po0.005. (c) Schematic of the
ncRNA-RB1 genomic locus in the human genome. Two splice forms of ncRNA-RB1 are annotated in the GENCODE V19 annotation (depicted in
dark orange). (d) Localization of transcripts in cellular fractions from A549 cells. The relative expression of ncRNA-RB1 within the cellular
fractions was determined by qRT–PCR. Relative expressions of 7SL and pre-GAPDH transcripts were determined as control for the purity of
cellular fractions. The mean values± s.d. are shown, n= 3 replicates.
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In order to identify targets of ncRNA-RB1 we performed RNA-
sequencing of poly(A)-enriched RNA from A549 cells after
treatment with siRNAs against ncRNA-RB1. Cells depleted of RB1
were used for comparison of gene expression differences
following knockdown of the two transcripts. The knockdown of
ncRNA-RB1 resulted in differential expression of 200 genes that
are not signiﬁcantly enriched in any particular GO term (Figure 4f
and Supplementary Table 3). The most highly regulated transcript
in terms of absolute change in RPKM encodes the protein CALR
(Figure 4g), an endoplasmic reticulum-sessile chaperone that has
been shown to be important for ICD by serving as an ‘eat-me’
signal presented by apoptotic cells.30,32 To further study the
regulation of CALR by ncRNA-RB1, we monitored CALR protein
levels following knockdown of ncRNA-RB1. Western blot analysis
revealed a more than 80 percent reduction of CALR protein levels
48 h after siRNA-mediated knockdown of ncRNA-RB1, showing
that the downregulation of CALR is pronounced also on the
protein level (Figure 5a). To determine whether the regulation of
CALR by ncRNA-RB1 occurred on the transcriptional level, we
subjected control or ncRNA-RB1-depleted cells to subcellular
fractionation, and determined the abundance of CALR mRNA in
chromatin-associated fractions (Figure 5b). A signiﬁcant decrease
in CALR mRNA levels was observed in the chromatin fraction,
suggesting a role of transcriptional regulation of CALR expression
by ncRNA-RB1 (Figure 5b). Decreased levels of ncRNA-RB1 were
observable, although not statistically signiﬁcant in the chromatin
fraction, possibly because of the inefﬁcient siRNA-mediated effects
on chromatin (Figure 5c). GAPDH levels on chromatin did not
show any changes following knockdown of ncRNA-RB1
(Figure 5d). We further determined the subcellular distribution
of CALR protein by immunoﬂuorescence staining of control and
ncRNA-RB1-depleted U2OS cells (Figure 6a). These results are in
accordance with the preponderant localization of CALR protein in
the endoplasmic reticulum.32 CALR reduction on the protein level
by more than 60 percent was further quantiﬁed by cytoﬂuoro-
metric analysis (Figure 6b).
Next, we addressed the functional impact of ncRNA-RB1 on

















































































































































Figure 4. ncRNA-RB1 and RB1 regulate distinct target genes. (a) Knockdown of ncRNA-RB1 in A549 cells using two different siRNAs against
ncRNA-RB1. As control, A549 cells were transfected with a non-targeting control siRNA. (b) Determination of RB1 expression levels following
knockdown of ncRNA-RB1 using two siRNAs. (c) Determination of ncRNA-RB1 expression levels following siRNA-mediated knockdown of RB1
mRNA. (d) Knockdown of RB1 mRNA in A549 cells using one siRNA. As control, A549 cells were transfected with a nontargeting control siRNA.
(e) Western blot analysis to determine RB1 protein levels following siRNA-mediated knockdown of RB1 mRNA and of ncRNA-RB1 in A549 cells.
β-actin protein levels are depicted as loading control. (f) Venn diagram depicting the number of regulated genes upon knockdown of ncRNA-
RB1 (red) and RB1 (blue) determined as described in Materials and methods. Upper diagram shows the total number of regulated genes for
each knockdown. The genes commonly regulated by ncRNA-RB1 and RB1 are depicted in gray. Lower diagrams show number of up- and
downregulated genes. (g) Determination of relative expression levels of the ncRNA-RB1 target gene CALR following knockdown of ncRNA-RB1
and knockdown of RB1 mRNA. Expression levels are presented relative to the value of Actin as reference gene as determined by qRT–PCR. The
mean values± s.d. are shown, n⩾ 3 replicates. ***Po0.005.
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cell removal. We therefore treated ncRNA-RB1-depleted U2OS
cells with mitoxantrone (MTX), a chemotherapeutic agent that
induces cell surface translocation of CALR.32,48 CALR exposed at
the cell membrane (ecto-CALR) was monitored by cell surface
immunoﬂuorescence staining of live cells followed by cytoﬂuoro-
metry. Ecto-CALR levels were strongly reduced upon depletion of
ncRNA-RB1 as compared with control cells (Figures 6c and d). As
cell surface exposure of CALR is a major stimulus of phagocytosis,
we hypothesized that a substantial decrease in ecto-CALR protein
levels would interfere with a subsequent uptake by immune cells.
Accordingly, as compared with controls, ncRNA-RB1 depletion
resulted in reduced uptake of MTX-treated cells by human
macrophages in an in vitro phagocytosis assay (Figures 6e and f).
DISCUSSION
The functions of long ncRNAs that are associated with the
promoters of PCGs remain mostly unclear, although this class of
transcripts is increasingly detected in many genome-wide studies
focusing on eukaryotic promoters.12,13,16,22,23 Previous studies
have proposed a role for PCG-associated antisense long ncRNAs in
the direct regulation of their protein partner, for example, by
interaction with the protein-coding DNA region or their com-
plementary mRNA.49,50 In contrast to these ﬁndings, the RB1
promoter-associated long ncRNA-RB1 described in this study does
not regulate the transcription of RB1. ncRNA-RB1 seems to
mediate tumor-inhibitory mechanisms through the regulation of
its target genes. The idea that co-transcription could entail
co-functionality of paired gene products is supported by the
observation that divergent PCG/PCG pairs in the human genome
(around 10% of all PCGs) are enriched in speciﬁc functional
categories, such as DNA repair and the regulation of cell cycle and
metabolism.51
As the annotated promoter region separating the TSSs of
ncRNA-RB1 and RB1 is only 114 bp in size, we reasoned that the
transcripts are likely to be co-expressed from a shared bidirec-
tional promoter. Conceptually, the transcript pairs originating from
relatively short bidirectional promoters should be regulated in a
coordinated manner, as on nucleosome-free promoters the
establishment of an active transcription environment on one
TSS facilitates transcription initiation by polymerase II also at the
divergent TSS.20 The experimental validation of bidirectional
promoter activity demonstrated the ability of the promoters to
initiate transcription in both directions. Reduced bidirectional
promoter activity upon introduction of single base pair mutations
argues for a regulation by the same transcription factors and
linked expression of the two transcripts. The high conservation
rate we observed for the set of bidirectional ncRNA/PCG
promoters further supports the importance of preservation of
regulatory elements such as transcription factor-binding sites. The
simultaneous transcription of long ncRNA/PCG pairs might be
mediated by shared binding sites within the promoter region.
Whereas the reporter assays for four candidate bidirectional
promoters showed similar capabilities to mediate transcription in
both directions, in vivo expression analysis for some of these
endogenous promoters by qPCR showed a 100-fold difference
between expression levels of long ncRNAs and PCGs for most
cases. This suggests that further regulatory mechanisms are
involved, affecting transcriptional elongation or post-
transcriptional stability of both RNAs, which could also explain
the low correlation in expression for some of the paired
transcripts. The exosome has been suggested to be involved in
the regulation of promoter-associated transcripts.14 However, our
attempts to demonstrate exosome involvement for selected long
ncRNAs did not yield statistical signiﬁcant differences.
The ncRNA-RB1 target gene CALR displayed the most
pronounced differential expression in terms of absolute change
in RPKM upon ncRNA-RB1 knockdown. The signiﬁcance of this
observation becomes clear when considering the high cellular
abundance of this endoplasmic reticulum-sessile protein and its
function as a major Ca2+-binding protein and chaperone. The
CALR protein has been shown to serve as an ‘eat-me’ signal for
immune cells when exposed to the plasma membrane.30,32,48,52
The transcriptional regulation of CALR by ncRNA-RB1 extended to
the surface translocation of CALR observed upon MTX treatment.
Whereas surface CALR was not directly affected by the knockdown
of ncRNA-RB1, the translocation upon MTX treatment was
markedly reduced. This difference in translocation was reﬂected
in the reduced uptake of cancer cells by human macrophages, and
thus assigns an important role to ncRNA-RB1 in the regulation of
immunogenic cell removal. It has been proposed recently that
tumorigenic cells are not only involved in disabling cell-intrinsic
death programs (such as apoptosis) but they must also avoid
programmed cell removal by phagocytes, a process that is also
referred to as ‘phagoptosis’.30 One of the aims of chemotherapy is
therefore to elicit an anticancer immune response by inducing the
uptake of dying cancer cells by phagocytes.
In conclusion, we showed that ncRNA-RB1 links the transcrip-
tion regulation of RB1 to expression of CALR and can mediate
differential recognition of cancer cells by macrophages in ICD. The
possibility that neoplastic cells can simultaneously abrogate
expression of RB1 and ncRNA-RB1, caused by, for example, RB1




The promoter regions of bidirectionally encoded long ncRNAs were
deﬁned as 700-bp regions surrounding the annotated TSS of long ncRNAs

































































































Figure 5. ncRNA-RB1 regulates CALR expression. (a) Western blot
analysis to determine CALR protein levels following siRNA-mediated
knockdown of ncRNA-RB1 in A549 cells. α-tubulin protein levels are
depicted as loading control. (b) CALR expression levels on
chromatin following knockdown of ncRNA-RB1 in A549 cells. (c)
Knockdown efﬁciency of ncRNA-RB1 on chromatin in A549 cells. (d)
GAPDH expression levels on chromatin following knockdown of
ncRNA-RB1. The relative expression of ncRNA-RB1, CALR and GAPDH
within the cellular fractions was determined by qRT–PCR. The mean
values± s.d. are shown, n= 3 replicates. ***Po0.005.
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ncRNA genes in general and PCGs were deﬁned in the same way. For
comparison, intergenic regions of 700 bp were extracted from random
locations in the genome and masked for repetitive regions. Ten promoter
sets of comparable size to the 1107 bidirectional promoters were
considered for each of the other promoter classes and the results were
averaged over 10 data sets. Position-wise conservation scores were
computed from the PhastCons vertebrate conservation track from UCSC.53
An average conservation score was then computed for each of the 700-bp
regions, and the distribution of these scores plotted for each class.
Cell culture
HEK293, A549 and U2OS cells were cultured in complete DMEM medium
(Gibco/LifeTechnologies, Carlsbad, CA, USA) supplemented with 10% fetal
bovine serum (FBS) and penicillin–streptomycin (Gibco) at 37 °C with 5%
CO2.
Cloning of pGL3 reporter plasmids
The KpnI and MluI sites in the pGL3-Basic vector (Promega, Fitchburg, WI,
USA) were used to insert the Renilla reniformis luciferase reporter gene
ampliﬁed from the pRL-TK vector (Promega), yielding a head-to-head
orientation of both reporter genes. Promoters were cloned into the BglII
and HindIII restriction sites.
Primer sequences: Renilla Luciferase (5′-GGACGCGTCACTATAGGCTAG
CCACCATGA-3′, 5′-GGGGTACCTGGATCCTTATCGATTTTACCA-3′), CCNG1
promoter (5′-GGAGATCTCAGCCGATTGACCTGACC-3′, 5′-GGAAGCTTGAGAC
AACTCGGCCCTGAT-3′), FKTN promoter (5′-GGAGATCTGGTGAGGATGCGAC
AAGAGT-3′, 5′-GGAAGCTTGAGCCTCCCGTACCTTACCT-3′), MAGOH promo-
ter (5′-GGAGATCTTGCAGTCTTGTTGCCACTTC-3′, 5′-GGAAGCTTGCCTGAACT
TCCAAGAGCAA-3′), RB1 promoter (5′-GGAAGCTTGCAACTGAGCGCCGC
GTC-3′, 5′-GGAGATCTAGCGCCCCAGTTCCCCAC-3′). The TK promoter was
exerted from the pRL-TK plasmid using BglII and HindIII restriction
enzymes.
Luciferase assay
HEK293 cells were transfected with Lipofectamine 2000 (LifeTechnologies)
in 96-well white plates with 200 ng of the respective plasmids. Twenty-four
hours after transfection, luciferase activity was measured using the Dual-
Glo Luciferase Assay System (Promega) according to the manufacturer’s
protocol. Fireﬂy and Renilla reniformis luciferase counts for promoters were
normalized to their respective counts in the no-promoter vector.
Quantitative real-time PCR
Total RNA was extracted from cells with TRIzol (Life Technologies)




















































































































Figure 6. Regulation of programmed cell removal by ncRNA-RB1. (a) Representative images of CALR protein expression (green) in U2OS cells
treated with siRNAs against ncRNA-RB1 or scrambled control siRNAs obtained by immunohistochemistry. The scale bar equals 10 μm. (b) Nine
view ﬁelds per condition were analyzed by automated image segmentation and the ﬂuorescence intensity of CALR immunostaining was
normalized to siRNA controls. (c, d) U2OS cells treated with siRNAs against ncRNA-RB1 or scrambled control siRNAs were subjected to 2 μM
MTX for 12 h and surface-exposed CALR was evaluated by immunohistochemistry and subsequent ﬂow cytometry. Dead cells were excluded
by counterstaining with propidium iodide and mean ﬂuorescence intensity as well as the percent of CALR-positive cells were determined.
Statistical analysis was conducted between the MTX-treated samples. (e, f) FITC-labeled macrophages were coincubated for 2 h with
celltracker orange stained U2OS cells treated with siRNAs and subjected to 2 μM MTX for 12 h as indicated. The celltracker ﬂuorescence
intensity of CD11b-FITC-labeled PBMC was measured as an indicator for tumor cell uptake. Mean values± s.d. are shown, n= 3 replicates.
*Po0.05.
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England Biolabs (NEB), Ipswich, MA, USA). cDNA was synthesized using the
High Capacity RNA-to-cDNA Kit (Life Technologies) and qPCR was
performed using the Fast SYBR Green Master Mix (Life Technologies) on
a 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA,
USA). The relative expression was calculated by normalizing to the Actin
expression level as reference control gene.
The sequences of the real-time primers are: ncRNA-CCNG1 (5′-AGT
GGTTCTGCCCCATCTTT-3′, 5′-GTGCTTTGAGAGGCCAAAGT-3′), CCNG1
mRNA (5′-TCACCTTCCAACAATTCCTGA-3′, 5′-AAGGTTGTGGAGAAAGGC
TTC-3′), ncRNA-PRKCQ (5′-GGTGGGACTGCTTTCAACTT-3′, 5′-GCTGTTATCC
GTTTGCCATT-3′), PRKCQ mRNA (5′-TGAGAGGTGCAGGAAGAACA-3′, 5′-GCC
TTCCGTCTCAAATTCAT-3′), ncRNA-RB1 (5′-GGACGTGCTTCTACCCAGAAC-3′,
5′-TCCTTCTCAGTTGACGAGTTCA-3′) , RB1 (5′-GAGCAAGGTCTAAGGCAGGA-
3′, 5′-CTGGCAGTTTGTTGCTTCAG-3′) and β-actin (5′-CGACAGGATGCAGA
AGGAG-3′, 5′-GTACTTGCGCTCAGGAGGAG-3′).
RNA interference
dsiRNA oligos from IDTDNA (si1 ncRNA-RB1: sense 5′-GACGCUAAGUCAUG
AGGAAUUAAAC-3′, antisense 5′-GUUUAAUUCCUCAUGACUUAGCGUCCC
-3′; si2 ncRNA-RB1: sense 5′-CUGAACUCGUCAACUGAGAAGGAAA-3′, anti-
sense 5′-UUUCCUUCUCAGUUGACGAGUUCAGAU-3′; si1 RB1: sense
5′-CUCCCAUGUUGCUCAAAGAACCATA-3′, antisense 5′-UAUGGUUCUUUGA
GCAACAUGGGAGGU-3′) were used. As a negative control we used DS NC1
(IDT DNA).
Cells were transfected at a ﬁnal dsiRNA concentration of 10 nM using
Lipofectamine 2000 (Life Technologies) according to the manufacturer’s
protocol. Cells were collected 24 h post transfection for RNA isolation and
48 h post transfection for western blot analysis.
RNA isolation and sequencing
Total RNA was extracted using TRIzol (Life Technologies) and RNAseq
libraries were prepared with the TruSeq RNA Sample Preparation Kit v2.
Sequencing was performed on a HiSeq 2000 instrument (Illumina, San
Diego, CA, USA) using paired-end sequencing (2 × 50 bp). Sequencing data
were subjected to the quality control (QC) using deﬁned metrics on an
automated quality-control pipeline that combines published tools as
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) with
in-house standardized methods. All reads that passed quality metrics
were mapped to the latest human genome build (UCSC hg19). Sequencing
duplicated reads were removed using PicardTools (http://picard.source
forge.net/). For alignment the most recent version of Bowtie254 and
TopHat255 were used. Read counting/summarizing was performed using
Cufﬂinks2.56
Immunoblotting
Proteins were resolved using NuPAGE 4–12% Bis-Tris gels (Life Technol-
ogies) and 1X NuPAGE MOPS SDS Running Buffer (Life Technologies) and
transferred onto PVDF membranes. Membranes were probed with a
primary antibody (mouse anti-RB1 (4H1, Cell Signaling), mouse anti-CALR
(FMC 75, Abcam), mouse anti-β-actin (8H10D10, Cell Signaling), mouse
anti-α-tubulin (DM1A, Cell Signaling)).
Cellular fractionation
Cellular fractions for RNA isolation were prepared from ~4× 106 cells as
described in57 except for the proteinase K treatment of cytoplasmic and
nuclear fractions.
Immunoﬂuorescence
Ten thousand human osteosarcoma U2OS cells seeded in poly-L-lysine-
coated 96-well Black/Clear Imaging Plates (BD Biosciences, Franklin Lakes,
NJ, USA) were subjected to siRNA-mediated knockdown of ncRNA-RB1 as
described above. Forty-eight hours later the cells were ﬁxed with 3.7%
paraformaldehyde (Sigma-Aldrich, St Louis, MO, USA) containing hoechst
33342 (Sigma-Aldrich), permeabilized with 0.1% triton-X100 and stained
with anti-CALR antibody (Abcam, Cambridge, UK) for 30min and
subsequent Alexaﬂuor-488-conjugated secondary antibody (Invitrogen,
Carlsbad, CA, USA) diluted in blocking buffer (2% FBS, v/v in phosphate-
buffered saline (PBS)). Nine view ﬁelds per well were acquired by means of
a Molecular Devices IXM XL automated microscope and images were
analyzed for cytoplasmic ﬂuorescence intensity by using the Metaxpress
software v. 5.1 (Molecular Devices, Sunnyvale, CA, USA).
Flow cytometry
Cells were collected, washed twice with PBS and thereafter incubated with
anti-CALR antibody (Abcam) diluted in cold blocking buffer (2% FBS, v/v in
PBS) for 30min on ice, followed by washing and incubation with
AlexaFluor 488
®
-conjugates (Invitrogen) in blocking buffer (for 30min).
Thereafter, cells were washed in cold PBS, PI was added to the ﬁnal
concentration of 1 μg/ml and samples were analyzed by means of a
FACScan cytoﬂuorometer (Becton Dickinson, Franklin Lakes, NJ, USA).
Isotype-matched IgG antibodies (Cell Signaling Technology, Danvers, USA)
were used as negative staining control, and the analysis was limited to
living (PI−) cells. Data were statistically evaluated by means of the Cell
Quest Software package (Becton Dickinson).
Macrophage uptake assay
Peripheral blood mononuclear cells (PBMCs) were isolated from freshly
harvested blood samples of healthy volunteers by means of Ficoll density
gradient centrifugation. Macrophages were puriﬁed using a CD11b-
positive selection (Miltenyi, Bergisch Gladbach, Germany) and labeled
with CD11b-FITC antibody (Miltenyi) following the manufacturer’s protocol.
Fluorescein isothiocyanate (FITC)-labeled macrophages were incubated for
2 h at 37 °C with orange cell tracker (Life technology)-stained U20S human
osteosarcoma cells, that were subjected to siRNA-mediated knockdown of
ncRNA-RB1 as described above and subsequently treated with 2 μM
mitoxantrone for additional 12 h to induce CALR surface exposure. Cells
were recovered and stained with the viability marker 4,6-diamidino-2-
phenylindole (Sigma) and immediately acquired on a Cyan ADP ﬂow
cytometer (Beckman Coulter, Brea, CA, USA). The uptake of apoptotic
tumor cells stained with cell tracker orange by CD11b-FITC-positive
macrophages was analyzed using the FlowJo software (Tree Star, Ashland,
OR, USA).
Statistics
Experiments were carried out in minimally three independent replicates.
Statistical analyses were performed using two-tailed Student’s t-test.
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